𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure

✍ Scribed by Fox, Kim; Ford, Ian; Steg, Philippe Gabriel; Tardif, Jean-Claude; Tendera, Michal; Ferrari, Roberto

Book ID
122596071
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
459 KB
Volume
166
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Rationale and design of a randomized, do
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study
✍ Kim Fox; Roberto Ferrari; Michal Tendera; Philippe Gabriel Steg; Ian Ford πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 193 KB
A multicentre, randomized, double-blind
A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial
✍ Olivier F. Bertrand; Paul Poirier; Josep RodΓ©s-Cabau; StΓ©phane Rinfret; Lawrence πŸ“‚ Article πŸ“… 2009 πŸ› Pulsus Group Inc 🌐 English βš– 803 KB
ABSORB II randomized controlled trial: A
ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design
✍ Roberto Diletti; Patrick W. Serruys; Vasim Farooq; Krishnankutty Sudhir; Cecile πŸ“‚ Article πŸ“… 2012 πŸ› Elsevier Science 🌐 English βš– 419 KB